Risk of hepatitis B virus reactivation following treatment with abatacept: A retrospective study of international pharmacovigilance databases

Wang, JJ; Zhang, X; Geng, XZ; Shi, JJ; Jia, XL; Dang, SS; Wang, WJ

Dang, SS; Wang, WJ (通讯作者),Xi An Jiao Tong Univ, Dept Infect Dis, Affiliated Hosp 2, Xian, Peoples R China.

ECLINICALMEDICINE, 2022; 48 ():

Abstract

Background Abatacept is a selective T-cell costimulation modulator approved for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, ......

Full Text Link